{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T16:11:32Z","timestamp":1774973492257,"version":"3.50.1"},"reference-count":80,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2005,12,1]],"date-time":"2005-12-01T00:00:00Z","timestamp":1133395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Best Practice &amp; Research Clinical Haematology"],"published-print":{"date-parts":[[2005,12]]},"DOI":"10.1016\/j.beha.2005.01.025","type":"journal-article","created":{"date-parts":[[2005,7,17]],"date-time":"2005-07-17T12:33:11Z","timestamp":1121603591000},"page":"689-707","source":"Crossref","is-referenced-by-count":29,"title":["Monoclonal gammopathies of undetermined significance"],"prefix":"10.1016","volume":"18","author":[{"given":"Robert A.","family":"Kyle","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Vincent Rajkumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.beha.2005.01.025_bib1","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.0954-6820.1966.tb05453.x","article-title":"Frequency of pathological proteins (M-components) in 6995 sera from an adult population","volume":"179","author":"Axelsson","year":"1966","journal-title":"Acta Med Scand"},{"key":"10.1016\/j.beha.2005.01.025_bib2","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1182\/blood.V40.5.719.719","article-title":"Incidence of monoclonal proteins in a Minnesota community with a cluster of multiple myeloma","volume":"40","author":"Kyle","year":"1972","journal-title":"Blood"},{"key":"10.1016\/j.beha.2005.01.025_bib3","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1136\/jcp.35.1.63","article-title":"Monoclonal gammopathies in the adult population of Finistere, France","volume":"35","author":"Saleun","year":"1982","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.beha.2005.01.025_bib4","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0002-9343(98)00080-1","article-title":"Racial differences in the prevalence of monoclonal gammopathy in a community-based sample of the elderly","volume":"104","author":"Cohen","year":"1998","journal-title":"Am J Med"},{"key":"10.1016\/j.beha.2005.01.025_bib5","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/0002-9343(78)90522-3","article-title":"Monoclonal gammopathy of undetermined significance: natural history in 241 cases","volume":"64","author":"Kyle","year":"1978","journal-title":"Am J Med"},{"key":"10.1016\/j.beha.2005.01.025_bib6","doi-asserted-by":"crossref","first-page":"859","DOI":"10.4065\/79.7.859","article-title":"Long-term follow-up of 241 patients with monoclonal gammopathy of undetermined significance: the original Mayo Clinic series 25 years later","volume":"79","author":"Kyle","year":"2004","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.beha.2005.01.025_bib7","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1056\/NEJMoa01133202","article-title":"A long-term study of prognosis in monoclonal gammopathy of undetermined significance","volume":"346","author":"Kyle","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.beha.2005.01.025_bib8","unstructured":"Surveillance, Epidemiology, and End Results (SEER) Program public-use data (1973\u20131998). Bethesda, Maryland: National Cancer Institute, Cancer Statistics Branch; April 2001."},{"key":"10.1016\/j.beha.2005.01.025_bib9","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1182\/blood.V79.7.1817.1817","article-title":"Incidence and natural history of primary systemic amyloidosis in Olmsted County, Minnesota, 1950 through 1989","volume":"79","author":"Kyle","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.beha.2005.01.025_bib10","doi-asserted-by":"crossref","first-page":"21","DOI":"10.4065\/78.1.21","article-title":"Review of 1027 patients with newly diagnosed multiple myeloma","volume":"78","author":"Kyle","year":"2003","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.beha.2005.01.025_bib11","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/j.0954-6820.1986.tb03349.x","article-title":"A 20-year follow-up study of 64 subjects with M-components","volume":"219","author":"Axelsson","year":"1986","journal-title":"Acta Med Scand"},{"key":"10.1016\/j.beha.2005.01.025_bib12","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.1365-2141.1992.tb08245.x","article-title":"Malignant transformation and life expectancy in monoclonal gammopathy of undetermined significance","volume":"81","author":"Blad\u00e9","year":"1992","journal-title":"Br J Haematol"},{"key":"10.1016\/j.beha.2005.01.025_bib13","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1046\/j.1365-2141.2002.03589.x","article-title":"Monoclonal gammopathy in Iceland: a population-based registry and follow-up","volume":"118","author":"\u00d6gmundsd\u00f3ttir","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1016\/j.beha.2005.01.025_bib14","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1200\/JCO.20.6.1625","article-title":"Prognostic factors for malignant transformation in monoclonal gammopathy of undetermined significance and smoldering multiple myeloma","volume":"20","author":"Cesana","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.beha.2005.01.025_bib15","first-page":"4546","article-title":"Intergroupe Francophone du My\u00e9lome. 14q32 translocations and monosomy 13 observed in monoclonal gammopathy of undetermined significance delineate a multistep process for the oncogenesis of multiple myeloma","volume":"59","author":"Avet-Loiseau","year":"1999","journal-title":"Cancer Res"},{"key":"10.1016\/j.beha.2005.01.025_bib16","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1182\/blood.V100.4.1417.h81602001417_1417_1424","article-title":"Genomic abnormalities in monoclonal gammopathy of undetermined significance","volume":"100","author":"Fonseca","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.beha.2005.01.025_bib17","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1182\/blood.V94.8.2583.420a05_2583_2589","article-title":"Intergroupe Francophone du My\u00e9lome. Monosomy 13 is associated with the transition of monoclonal gammopathy of undetermined significance to multiple myeloma","volume":"94","author":"Avet-Loiseau","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.beha.2005.01.025_bib18","first-page":"350a","article-title":"Cytogenetic abnormalities in systemic amyloidosis: a comparison of conventional cytogenetic analysis to fluorescent in-situ hybridization with simultaneous cytoplasmic immunoglobulin staining [abstract]","volume":"90","author":"Fonseca","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.beha.2005.01.025_bib19","first-page":"3111","article-title":"Prognostic value of bone marrow angiogenesis in multiple myeloma","volume":"6","author":"Rajkumar","year":"2000","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.beha.2005.01.025_bib20","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1182\/blood-2003-11-3811","article-title":"Bone marrow angiogenic ability and expression of angiogenic cytokines in myeloma: evidence favoring loss of marrow angiogenesis inhibitory activity with disease progression","volume":"104","author":"Kumar","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.beha.2005.01.025_bib21","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1359\/jbmr.2002.17.11.1921","article-title":"Role of the bone marrow microenvironment in multiple myeloma","volume":"17","author":"Roodman","year":"2002","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.beha.2005.01.025_bib22","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1182\/blood.V100.6.2195","article-title":"Role for macrophage inflammatory protein (MIP)-1\u03b1 and MIP-1\u03b2 in the development of osteolytic lesions in multiple myeloma","volume":"100","author":"Abe","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.beha.2005.01.025_bib23","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1177\/107327489800500301","article-title":"Biology of the transition of monoclonal gammopathy of undetermined significance (MGUS) to multiple myeloma","volume":"5","author":"Lust","year":"1998","journal-title":"Cancer Control"},{"key":"10.1016\/j.beha.2005.01.025_bib24","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1056\/NEJM198006123022405","article-title":"Smoldering multiple myeloma","volume":"302","author":"Kyle","year":"1980","journal-title":"N Engl J Med"},{"key":"10.1016\/j.beha.2005.01.025_bib25","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1182\/blood.V87.3.912.bloodjournal873912","article-title":"Role of different hematologic variables in defining the risk of malignant transformation in monoclonal gammopathy","volume":"87","author":"Baldini","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.beha.2005.01.025_bib26","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1056\/NEJM198203113061002","article-title":"\u2018Idiopathic\u2019 Bence Jones proteinuria: long-term follow-up in seven patients","volume":"306","author":"Kyle","year":"1982","journal-title":"N Engl J Med"},{"key":"10.1016\/j.beha.2005.01.025_bib27","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/S0025-6196(12)65066-6","article-title":"Immunofluorescence labeling indices in myeloma and related monoclonal gammopathies","volume":"62","author":"Greipp","year":"1987","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.beha.2005.01.025_bib28","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/j.1365-2141.1994.tb04908.x","article-title":"Detection of peripheral blood plasma cells as a predictor of disease course in patients with smouldering multiple myeloma","volume":"87","author":"Witzig","year":"1994","journal-title":"Br J Haematol"},{"key":"10.1016\/j.beha.2005.01.025_bib29","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1097\/00007632-199711010-00017","article-title":"GRI Study Group. Magnetic resonance appearance of monoclonal gammopathies of unknown significance and multiple myeloma","volume":"22","author":"Bellaiche","year":"1997","journal-title":"Spine"},{"key":"10.1016\/j.beha.2005.01.025_bib30","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/j.1600-0609.1997.tb00932.x","article-title":"Abnormal bone turnover in monoclonal gammopathy of undetermined significance: analyses of type I collagen telopeptide, osteocalcin, bone-specific alkaline phosphatase and propeptides of type I and type III procollagens","volume":"58","author":"Vejlgaard","year":"1997","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.beha.2005.01.025_bib31","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1093\/clinchem\/48.9.1437","article-title":"Serum reference intervals and diagnostic ranges for free \u03ba and free \u03bb immunoglobulin light chains: relative sensitivity for detection of monoclonal light chains","volume":"48","author":"Katzmann","year":"2002","journal-title":"Clin Chem"},{"key":"10.1016\/j.beha.2005.01.025_bib32","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1111\/j.1365-2141.2004.05169.x","article-title":"Presence of monoclonal free light chains in the serum predicts risk of progression in monoclonal gammopathy of undetermined significance","volume":"127","author":"Rajkumar","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1016\/j.beha.2005.01.025_bib33","unstructured":"Rajkumar SV, Kyle RA, Therneau TM et al. Presence of an abnormal serum free light ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance (MGUS). Submitted for publication."},{"key":"10.1016\/j.beha.2005.01.025_bib34","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1182\/blood.V96.6.2037","article-title":"Solitary plasmacytoma of bone and asymptomatic multiple myeloma","volume":"96","author":"Dimopoulos","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.beha.2005.01.025_bib35","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0002-9343(93)90120-E","article-title":"Risk of disease progression in asymptomatic multiple myeloma","volume":"94","author":"Dimopoulos","year":"1993","journal-title":"Am J Med"},{"key":"10.1016\/j.beha.2005.01.025_bib36","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1046\/j.1365-2141.1997.1122939.x","article-title":"Prognostic features of asymptomatic multiple myeloma","volume":"97","author":"Weber","year":"1997","journal-title":"Br J Haematol"},{"key":"10.1016\/j.beha.2005.01.025_bib37","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1046\/j.1365-2141.1999.01244.x","article-title":"Prognostic value of vertebral lesions detected by magnetic resonance imaging in patients with stage I multiple myeloma","volume":"104","author":"Mariette","year":"1999","journal-title":"Br J Haematol"},{"key":"10.1016\/j.beha.2005.01.025_bib38","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1200\/JCO.1995.13.1.251","article-title":"Prognostic significance of magnetic resonance imaging in patients with asymptomatic multiple myeloma","volume":"13","author":"Moulopoulos","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.beha.2005.01.025_bib39","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1600-0609.1993.tb00148.x","article-title":"Myeloma Group of Western Sweden. Initial versus deferred melphalan\u2013prednisone therapy for asymptomatic multiple myeloma stage I: a randomized study","volume":"50","author":"Hjorth","year":"1993","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.beha.2005.01.025_bib40","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/bjc.1996.212","article-title":"A prognostic index for multiple myeloma","volume":"73","author":"Grignani","year":"1996","journal-title":"Br J Cancer"},{"key":"10.1016\/j.beha.2005.01.025_bib41","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/0002-9343(81)90326-0","article-title":"The clinical aspects of biclonal gammopathies: review of 57 cases","volume":"71","author":"Kyle","year":"1981","journal-title":"Am J Med"},{"key":"10.1016\/j.beha.2005.01.025_bib42","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/S0248-8663(97)80618-2","article-title":"Triclonal gammopathy and malignant immunoproliferative syndrome [French]","volume":"18","author":"Grosbois","year":"1997","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.beha.2005.01.025_bib43","doi-asserted-by":"crossref","first-page":"3759","DOI":"10.1182\/blood-2003-03-0801","article-title":"Long-term follow-up of IgM monoclonal gammopathy of undetermined significance","volume":"102","author":"Kyle","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.beha.2005.01.025_bib44","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/j.1365-2141.1994.tb05037.x","article-title":"IgD monoclonal gammopathy with long-term follow-up","volume":"88","author":"Blad\u00e9","year":"1994","journal-title":"Br J Haematol"},{"key":"10.1016\/j.beha.2005.01.025_bib45","series-title":"Myeloma: Biology and Management","first-page":"315","article-title":"Monoclonal gammopathies of undetermined significance","author":"Kyle","year":"2004"},{"key":"10.1016\/j.beha.2005.01.025_bib46","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/0002-9343(57)90197-3","article-title":"Malignant lymphoma and lymphatic leukemia associated with myeloma-type serum proteins","volume":"23","author":"Azar","year":"1957","journal-title":"Am J Med"},{"key":"10.1016\/j.beha.2005.01.025_bib47","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1001\/jama.1960.03030030025005","article-title":"Diagnostic criteria for electrophoretic patterns of serum and urinary proteins in multiple myeloma: study of one hundred and sixty-five multiple myeloma patients and of seventy-seven nonmyeloma patients with similar electrophoretic patterns","volume":"174","author":"Kyle","year":"1960","journal-title":"JAMA"},{"key":"10.1016\/j.beha.2005.01.025_bib48","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1001\/archinte.135.1.62","article-title":"Monoclonal gammopathy in lymphoma","volume":"135","author":"Alexanian","year":"1975","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.beha.2005.01.025_bib49","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S0025-6196(12)65225-2","article-title":"The spectrum of IgM monoclonal gammopathy in 430 cases","volume":"62","author":"Kyle","year":"1987","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.beha.2005.01.025_bib50","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/0002-9343(87)90942-9","article-title":"Plasma cell leukemia: an evaluation of response to therapy","volume":"83","author":"Noel","year":"1987","journal-title":"Am J Med"},{"key":"10.1016\/j.beha.2005.01.025_bib51","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/S1297-319X(01)00343-8","article-title":"Myeloma and monoclonal gammopathy of uncertain significance associated with acquired von Willebrand's syndrome: seven new cases with a literature review","volume":"69","author":"Lamboley","year":"2002","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.beha.2005.01.025_bib52","doi-asserted-by":"crossref","unstructured":"Kelly JJ Jr., Kyle RA, O'Brien PC & Dyck PJ. Prevalence of monoclonal protein in peripheral neuropathy. Neurology 1981; 31: 1480\u20131483.","DOI":"10.1212\/WNL.31.11.1480"},{"key":"10.1016\/j.beha.2005.01.025_bib53","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1056\/NEJM199805283382207","article-title":"Neuropathies associated with paraproteinemia","volume":"338","author":"Ropper","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.beha.2005.01.025_bib54","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1002\/(SICI)1097-4598(199907)22:7<800::AID-MUS2>3.0.CO;2-F","article-title":"Autoantibodies associated with peripheral neuropathy","volume":"22","author":"Quarles","year":"1999","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.beha.2005.01.025_bib55","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/ana.410300111","article-title":"Neuropathy associated with monoclonal gammopathies of undetermined significance","volume":"30","author":"Gosselin","year":"1991","journal-title":"Ann Neurol"},{"key":"10.1016\/j.beha.2005.01.025_bib56","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1212\/WNL.43.11.2202","article-title":"Presentation and initial clinical course in patients with chronic inflammatory demyelinating polyradiculoneuropathy: comparison of patients without and with monoclonal gammopathy","volume":"43","author":"Simmons","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.beha.2005.01.025_bib57","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1056\/NEJM199111213252105","article-title":"Plasma exchange in polyneuropathy associated with monoclonal gammopathy of undetermined significance","volume":"325","author":"Dyck","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.beha.2005.01.025_bib58","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1177\/039139889902200109","article-title":"Plasma-exchange in chronic peripheral neurological disorders","volume":"22","author":"Mazzi","year":"1999","journal-title":"Int J Artif Organs"},{"key":"10.1016\/j.beha.2005.01.025_bib59","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1212\/WNL.40.4.595","article-title":"Motor neuron disease and amyotrophic lateral sclerosis: relation of high CSF protein content to paraproteinemia and clinical syndromes","volume":"40","author":"Younger","year":"1990","journal-title":"Neurology"},{"key":"10.1016\/j.beha.2005.01.025_bib60","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s100249900046","article-title":"Monoclonal gammopathy of the immunoglobulin A class in a two-year-old girl with ataxia telangiectasia","volume":"1","author":"McDonald","year":"1998","journal-title":"Pediatr Dev Pathol"},{"key":"10.1016\/j.beha.2005.01.025_bib61","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1097\/00005792-199911000-00002","article-title":"Oligo-\/monoclonal gammopathy and hypergammaglobulinemia in ataxia-telangiectasia: a study of 90 patients","volume":"78","author":"Sadighi Akha","year":"1999","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.beha.2005.01.025_bib62","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1182\/blood-2002-07-2299","article-title":"POEMS syndrome: definitions and long-term outcome","volume":"101","author":"Dispenzieri","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.beha.2005.01.025_bib63","doi-asserted-by":"crossref","first-page":"3400","DOI":"10.1182\/blood-2004-05-2046","article-title":"Peripheral blood stem cell transplant in 16 patients with POEMS syndrome and review of the literature","volume":"104","author":"Dispenzieri","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.beha.2005.01.025_bib64","first-page":"153","article-title":"Studies on a unique diagnostic serum globulin in papular mucinosis (lichen myxedematosus)","volume":"2","author":"James","year":"1967","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.beha.2005.01.025_bib65","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1365-2133.1983.tb03553.x","article-title":"Discoid lupus erythematosus and monoclonal gammopathy","volume":"109","author":"Powell","year":"1983","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.beha.2005.01.025_bib66","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1097\/00005792-198611000-00003","article-title":"Necrobiotic xanthogranuloma with paraproteinemia: a review of 22 cases","volume":"65","author":"Finan","year":"1986","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.beha.2005.01.025_bib67","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0190-9622(99)70434-2","article-title":"Monoclonal gammopathies and associated skin disorders","volume":"40","author":"Daoud","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.beha.2005.01.025_bib68","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1093\/ajcp\/77.5.619","article-title":"Primary hyperparathyroidism and monoclonal gammopathy of undetermined significance","volume":"77","author":"Mundis","year":"1982","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.beha.2005.01.025_bib69","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1001\/archinte.162.4.464","article-title":"Prevalence of monoclonal gammopathy in patients with primary hyperparathyroidism: a prospective study","volume":"162","author":"Arnulf","year":"2002","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.beha.2005.01.025_bib70","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/lt.500020508","article-title":"Development of monoclonal gammopathy precedes the development of Epstein\u2013Barr virus-induced posttransplant lymphoproliferative disorder","volume":"2","author":"Badley","year":"1996","journal-title":"Liver Transpl Surg"},{"key":"10.1016\/j.beha.2005.01.025_bib71","doi-asserted-by":"crossref","first-page":"3518","DOI":"10.1182\/blood.V91.9.3518","article-title":"Oligoclonal protein bands and Ig isotype switching in multiple myeloma treated with high-dose therapy and hematopoietic cell transplantation","volume":"91","author":"Zent","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.beha.2005.01.025_bib72","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1016\/S0041-1345(00)02602-6","article-title":"Monoclonal gammopathy in heart transplantation: risk factor analysis and relevance of immunosuppressive load","volume":"33","author":"Caforio","year":"2001","journal-title":"Transplant Proc"},{"key":"10.1016\/j.beha.2005.01.025_bib73","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1159\/000168712","article-title":"Long-term follow-up of monoclonal gammopathy of undetermined significance in transplant patients","volume":"14","author":"Rostaing","year":"1994","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.beha.2005.01.025_bib74","first-page":"350","article-title":"Monoclonal immunoglobulins with antibody activity in myeloma, macroglobulinemia and related plasma cell dyscrasias","volume":"13","author":"Merlini","year":"1986","journal-title":"Semin Oncol"},{"key":"10.1016\/j.beha.2005.01.025_bib75","first-page":"572","article-title":"Artifactual hypercalcemia in multiple myeloma","volume":"57","author":"Annesley","year":"1982","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.beha.2005.01.025_bib76","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/00005792-197907000-00004","article-title":"Acquired C1 esterase inhibitor deficiency and angioedema: a review","volume":"58","author":"Gelfand","year":"1979","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.beha.2005.01.025_bib77","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/S0002-9343(02)01124-5","article-title":"Prevalence of monoclonal gammopathy in patients presenting with acquired angioedema type 2","volume":"113","author":"Fremeaux-Bacchi","year":"2002","journal-title":"Am J Med"},{"key":"10.1016\/j.beha.2005.01.025_bib78","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/0002-9343(92)90749-2","article-title":"Control of systemic capillary leak syndrome with aminophylline and terbutaline","volume":"92","author":"Droder","year":"1992","journal-title":"Am J Med"},{"key":"10.1016\/j.beha.2005.01.025_bib79","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1001\/archinte.161.6.864","article-title":"Monoclonal gammopathy of undetermined significance and exposure to breast implants","volume":"161","author":"Karlson","year":"2001","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.beha.2005.01.025_bib80","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/0002-9394(89)90225-0","article-title":"Incidence of corneal crystals in the monoclonal gammopathies","volume":"107","author":"Bourne","year":"1989","journal-title":"Am J Ophthalmol"}],"container-title":["Best Practice &amp; Research Clinical Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521692605000289?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521692605000289?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,8]],"date-time":"2020-04-08T07:53:43Z","timestamp":1586332423000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521692605000289"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,12]]},"references-count":80,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005,12]]}},"alternative-id":["S1521692605000289"],"URL":"https:\/\/doi.org\/10.1016\/j.beha.2005.01.025","relation":{},"ISSN":["1521-6926"],"issn-type":[{"value":"1521-6926","type":"print"}],"subject":[],"published":{"date-parts":[[2005,12]]}}}